Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies: Experience From the Italian Network
Sara Bortolani,Marco Savarese,Gaetano Vattemi,Silvia Bonanno,Yuri M Falzone,Alessia Pugliese,Guido Primiano,Cristina Sancricca,Diego Lopergolo,Giulia Greco,Chiara Gemelli,Sabrina Ravaglia,Roberta P Bencivenga,Daniele Velardo,Francesca Magri,Maria L Valentino,Marta Cheli,Eleonora Torchia,Matteo Lucchini,Antonio Petrucci,Giulia Ricci,Matteo Garibaldi,Guja Astrea,Anna Rubegni,Corrado I Angelini,Alessandra Ariatti,Filippo M Santorelli,Alessandra Ruggieri,Giovanni Antonini,Gabriele Siciliano,Massimiliano Filosto,Massimiliano Mirabella,Rocco Liguori,Giacomo P Comi,Lucia Ruggiero,Marina Grandis,Roberto Massa,Alessandro Malandrini,Serenella Servidei,Tiziana E Mongini,Carmelo Rodolico,Antonio Toscano,Stefano C Previtali,Paola Tonin,Jordi Diaz-Manera,Mauro Monforte,Enzo Ricci,Lorenzo Maggi,Giorgio Tasca
DOI: https://doi.org/10.1212/WNL.0000000000209697
IF: 9.9
2024-08-27
Neurology
Abstract:Background and objectives: The diagnostic process for myofibrillar myopathies (MFM) and distal myopathies (DM) is particularly complex because of the large number of causative genes, the existence of still molecularly undefined disease entities, and the overlapping features between the 2 categories. This study aimed to characterize a large cohort of patients affected by MFM and DM and identify the most important diagnostic and prognostic aspects of these diseases. Methods: Patients with either a myopathological diagnosis of MFM or a clinical diagnosis of DM were included in this retrospective multicentric national study. Demographic, genetic, clinical, and histopathologic data of anonymized patients were collected from the neuromuscular centers of the Italian Association of Myology network. Results: Data regarding 132 patients with MFM (mean age 57.0 ± 15.8 years, 49% female) and 298 patients with DM (mean age 50.7 ± 15.9 years, 40% female) were gathered from 20 neuromuscular centers. 69 patients fulfilled the criteria for both groups (distal myopathies with myofibrillar pathology, DM-MP). Molecular confirmation was achieved in 63% of the patients. Fifty-two percent of the patients with MFM carried pathogenic variants in either DES (n = 30), MYOT (n = 20), or DNAJB6 (n = 18), which were also the most frequent disease-causing genes in DM-MP, while GNE (n = 44) and MYH7 (n = 23) were the genes most commonly carrying pathogenic variants in DM. The mean age at onset varied from <25 years in patients with causative variants in MYH7 and DYSF to 59 years in patients with myotilinopathies. Cardiac involvement was reported in 29% of patients with MFM and 16% of patients with DM, with DES and MYH7 variants significantly associated with the development of cardiomyopathy. Respiratory impairment was more prevalent in patients with TTN and DES variants and rare in other disorders such as GNE myopathy and dysferlinopathies, which were instead associated, together with DNAJB6-related and PLIN4-related myopathies, with the risk of losing ambulation during the disease course. Discussion: The Italian cohort of patients with MFM and DM recapitulates the phenotypic heterogeneity and the partial overlap between the 2 groups. However, in relative contrast to the encountered phenotypic variability, only 5 genes accounted for most of the molecular diagnoses. Specific genetic entities are associated with significantly increased risk of developing cardiorespiratory complications or loss of ambulation, which has relevant prognostic implications.